We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 21, 2021

Mutation Status and Homologous Recombination Deficiency in Tumors of Patients With Germline BRCA1/2 Mutations and Metastatic Breast Cancer

Annals of Oncology


Additional Info

Annals of Oncology
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD
Ann. Oncol 2021 Sep 06;[EPub Ahead of Print], D Hodgson, Z Lai, S Dearden, JC Barrett, EA Harrington, K Timms, J Lanchbury, W Wu, A Allen, E Senkus, SM Domchek, M Robson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading